Norma Beauchamp

Norma Beauchamp is a declared insider of Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation), with filings sourced from SEDI. Between 26 June 2015 and 4 November 2016, the trades on record add up to 3 filings.

Every open-market trade on record is a purchase: 2 purchases worth €3,270, and no sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. So far in 2016, the count stands at 2 purchases and no sales.

Most recently, on 4 November 2016, the filings show an open-market purchase worth €1,715 in Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation). Filings reach the SEDI feed a median of 1 day after the trade. That lag is the time during which only the insider knows about the trade. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.